Objective <p>This study aimed to evaluate the value of simultaneous multislice diffusion kurtosis imaging (SMS-DKI) for predicting early recurrence (within 2 years) in hepatocellular carcinoma (HCC) and to develop a predictive model.</p> Materials and methods <p>This prospective study included 67 HCC patients who underwent SMS-DKI on a 3-T MRI between June 2021 and January 2023. Diffusion parameters, including the apparent diffusion coefficient (ADC), SMS-mean kurtosis (SMS-MK), and SMS-mean diffusivity (SMS-MD), along with radiological features, were analyzed. Logistic regression models were used to predict early recurrence, internally validated using 10-fold cross-validation, and assessed using AUC, calibration curves, and decision curve analysis (DCA).</p> Results <p>Among 67 patients (58 males; mean age, 53.5 ± 9.9 years), 30 (44.8%) experienced early recurrence. The early recurrence had significantly lower ADC (1.12 vs 1.22 × 10<sup>−3</sup> mm<sup>2</sup>/s) and SMS-MD (1.45 vs 1.70 × 10<sup>−3</sup> mm<sup>2</sup>/s), and higher SMS-MK (0.91 vs 0.75). SMS-MK showed the highest AUC (0.90, 95% CI: 0.80–0.96). Multivariate analysis identified SMS-MK (OR = 3.43 [1.31–8.89]), tumor size (OR = 4.22 [1.58–7.76]), non-smooth tumor margin (OR = 2.68 [1.58–7.96]), and complete capsule (OR = 0.22 [0.02–0.79]) as independent predictors of early recurrence. Based on these four parameters, the final model achieved an AUC of 0.94 (95% CI: 0.88–1.00). Calibration curves and DCA confirmed clinical utility.</p> Conclusion <p>SMS-DKI enhances early recurrence prediction in HCC. The predictive model, incorporating SMS-MK, tumor size, and key radiological features, demonstrated good prognostic value.</p> Key Points <p><Emphasis Type="BoldItalic">Question</Emphasis> <i>Can SMS-DKI predict HCC early recurrence within 2 years post-surgery</i>?</p> <p><Emphasis Type="BoldItalic">Findings</Emphasis> <i>Higher SMS-MK, larger tumor size, non-smooth margins, and incomplete capsule predict HCC early recurrence (model AUC = 0.94)</i>.</p> <p><Emphasis Type="BoldItalic">Clinical relevance</Emphasis> <i>Integrating preoperative SMS-DKI biomarkers (SMS-MK) with tumor size and capsule status stratifies early HCC recurrence risk, guiding surgical planning and postoperative management</i>.</p> Graphical Abstract <p></p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Preoperative prediction of early recurrence in hepatocellular carcinoma using simultaneous multislice diffusion kurtosis imaging

  • Yingyi Wu,
  • Zheng Ye,
  • Ting Yang,
  • Shan Yao,
  • Jie Chen,
  • Ting Yin,
  • Bin Song

摘要

Objective

This study aimed to evaluate the value of simultaneous multislice diffusion kurtosis imaging (SMS-DKI) for predicting early recurrence (within 2 years) in hepatocellular carcinoma (HCC) and to develop a predictive model.

Materials and methods

This prospective study included 67 HCC patients who underwent SMS-DKI on a 3-T MRI between June 2021 and January 2023. Diffusion parameters, including the apparent diffusion coefficient (ADC), SMS-mean kurtosis (SMS-MK), and SMS-mean diffusivity (SMS-MD), along with radiological features, were analyzed. Logistic regression models were used to predict early recurrence, internally validated using 10-fold cross-validation, and assessed using AUC, calibration curves, and decision curve analysis (DCA).

Results

Among 67 patients (58 males; mean age, 53.5 ± 9.9 years), 30 (44.8%) experienced early recurrence. The early recurrence had significantly lower ADC (1.12 vs 1.22 × 10−3 mm2/s) and SMS-MD (1.45 vs 1.70 × 10−3 mm2/s), and higher SMS-MK (0.91 vs 0.75). SMS-MK showed the highest AUC (0.90, 95% CI: 0.80–0.96). Multivariate analysis identified SMS-MK (OR = 3.43 [1.31–8.89]), tumor size (OR = 4.22 [1.58–7.76]), non-smooth tumor margin (OR = 2.68 [1.58–7.96]), and complete capsule (OR = 0.22 [0.02–0.79]) as independent predictors of early recurrence. Based on these four parameters, the final model achieved an AUC of 0.94 (95% CI: 0.88–1.00). Calibration curves and DCA confirmed clinical utility.

Conclusion

SMS-DKI enhances early recurrence prediction in HCC. The predictive model, incorporating SMS-MK, tumor size, and key radiological features, demonstrated good prognostic value.

Key Points

Question Can SMS-DKI predict HCC early recurrence within 2 years post-surgery?

Findings Higher SMS-MK, larger tumor size, non-smooth margins, and incomplete capsule predict HCC early recurrence (model AUC = 0.94).

Clinical relevance Integrating preoperative SMS-DKI biomarkers (SMS-MK) with tumor size and capsule status stratifies early HCC recurrence risk, guiding surgical planning and postoperative management.

Graphical Abstract